Atara, FDA
Atara's New Drug Applications Placed on Hold by FDA
Atara Biotherapeutics said the U.S. Food and Drug Administration placed a clinical hold on its active investigational new drug applications. The biotechnology company said the FDA put a hold on its Ebvallo and ATA3219 programs due to compliance issues at a third-party manufacturing facility.
A Belgian court dismissed a lawsuit against EU chief Ursula von der Leyen centered on text messages she exchanged with Pfizer ...
Johnson & Johnson beat Wall Street’s fourth-quarter expectations as strong cancer drug sales compensated for a decline in ...
The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the body or cannot be surgically removed.
The controversial artificial food dye Red 3 was banned Wednesday by the Food and Drug Administration nearly 35 years after ...
FDA officials have telegraphed the decision for months. While the agency has long said that it did not think evidence of Red ...
The U.S. Food and Drug Administration has officially banned red dye — called Red 3, or Erythrosine — from foods, dietary ...
The FDA approved datopotamab deruxtecan-dlnk for treatment of certain patients with advanced breast cancer.The indication ...
Scientists have developed a single-dose treatment for breast cancer that eliminates small tumors and significantly shrinks ...
The Irish News on MSN12d
Drug breakthrough offers hope for advanced prostate cancer patientsResearch suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...
Johnson & Johnson, fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular, reported fourth-quarter sales ...
The U.S. Food and Drug Administration said on Wednesday it was adding a warning about the risk of a rare but serious allergic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback